hero section gradient
18 handpicked stocks

US Consumer Spending Stocks to Watch in 2025

U.S. retail sales have exceeded expectations for the third straight month, signaling robust consumer health. This theme focuses on companies poised to benefit from sustained consumer spending, particularly in strong-performing sectors like online retail and food services.

Author avatar

Han Tan | Market Analyst

Published on September 17

Your Basket's Financial Footprint

Market capitalisation summary for a US consumer spending stock basket, showing concentration in a few very large-cap names.

Key Takeaways for Investors:
  • Large-cap dominance tends to lower volatility, offering more stable, broadly market-tracking returns versus high-growth baskets.
  • Best used as a core holding for diversified portfolios, not a speculative or short-term trade.
  • Expect steady, long-term value; unlikely to produce explosive short-term gains for risk-seeking investors.
Total Market Cap
  • WMT: $846.88B

  • COST: $415.48B

  • KR: $44.80B

  • Other

About This Group of Stocks

1

Our Expert Thinking

US retail sales have exceeded expectations for three consecutive months, with August showing 0.6% growth and total sales reaching approximately £732 billion. This sustained consumer resilience signals a robust economic foundation that could support companies directly exposed to consumer spending across the retail value chain.

2

What You Need to Know

This group spans the entire retail ecosystem, from large department stores and grocery chains to specialised e-commerce platforms and food service distributors. The companies selected have direct exposure to consumer purchasing power, making them well-positioned to benefit from continued spending strength in key growth sectors.

3

Why These Stocks

These companies were handpicked by professional analysts based on their positioning within sectors showing significant year-over-year growth, particularly online retail and food services. Each stock represents a strategic play on the current robust state of the US consumer and their sustained demand patterns.

Why You'll Want to Watch These Stocks

🚀

Consumer Momentum Building

Three consecutive months of retail sales beating expectations suggests genuine consumer strength, not just a temporary blip. This sustained momentum could drive revenue growth across the retail ecosystem.

🎯

Fed Policy Implications

Strong consumer spending data influences Federal Reserve decisions on interest rates and monetary policy. Companies positioned in this space could benefit from favourable economic conditions ahead.

Sector Leaders Included

This group features established players and growth companies across retail, e-commerce, and food services - sectors showing the strongest year-over-year performance in recent data.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions